Paydirt
SP
Insider

Sanj K Patel

CHAIRMAN & CEO · Kiniksa Pharmaceuticals International

Sanj K Patel (CHAIRMAN & CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $37.4M of KNSA (402,394 sh across 14 lots, as filed), executed Oct 30. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$81.1M
shares × price, as filed
Last traded
Nov 4
Filed Nov 6

Median ADV $60.8M across their filed names

Open performance→
Volume by month
$51.7M$25.9M$0Dec 2024Jun 2025Dec 2025Jun 2026May 2025 · sells $2.5MOct 2025 · sells $10.0MApr 2026 · sells $26.8MMay 2026 · sells $2.6MNov 2026 · sells $51.7M
Buys $0 Sells $93.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names
KNSA Kiniksa Pharmaceuticals International, plc KNSA · 0 buys · 9 sells 9 filings
Recent filings
KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.1M
89,561 sh × $23.00
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET